| Technology of mammalian cell encapsulation H Uludag, P De Vos, PA Tresco Advanced drug delivery reviews 42 (1-2), 29-64, 2000 | 846 | 2000 |
| Current state of fabrication technologies and materials for bone tissue engineering A Wubneh, EK Tsekoura, C Ayranci, H Uludağ Acta Biomaterialia 80, 1-30, 2018 | 337 | 2018 |
| Characterization of rhBMP‐2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model H Uludag, D D'Augusta, R Palmer, G Timony, J Wozney Journal of Biomedical Materials Research: An Official Journal of The Society …, 1999 | 317 | 1999 |
| Carrier systems for bone morphogenetic proteins. SR Winn, H Uludag, JO Hollinger Clinical Orthopaedics and Related Research (1976-2007) 367, S95-S106, 1999 | 290 | 1999 |
| Delivery systems for BMPs: factors contributing to protein retention at an application site H Uludag, T Gao, TJ Porter, W Friess, JM Wozney JBJS 83 (1), S128-S135, 2001 | 280 | 2001 |
| ‘Magic bullets’ for bone diseases: progress in rational design of bone-seeking medicinal agents S Zhang, G Gangal, H Uludağ Chemical Society Reviews 36 (3), 507-531, 2007 | 273 | 2007 |
| Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: a correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model H Uludag, D D'Augusta, J Golden, J Li, G Timony, R Riedel, JM Wozney Journal of Biomedical Materials Research: An Official Journal of The Society …, 2000 | 239 | 2000 |
| Nanofibers as new-generation materials: From spinning and nano-spinning fabrication techniques to emerging applications A Barhoum, K Pal, H Rahier, H Uludag, IS Kim, M Bechelany Applied Materials Today 17, 1-35, 2019 | 236 | 2019 |
| Sustained release emphasizing recombinant human bone morphogenetic protein-2 SR Winn, H Uludag, JO Hollinger Advanced drug delivery reviews 31 (3), 303-318, 1998 | 235 | 1998 |
| Nanoparticulate systems for growth factor delivery S Zhang, H Uludağ Pharmaceutical research 26, 1561-1580, 2009 | 202 | 2009 |
| Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression A Neamnark, O Suwantong, RB KC, CYM Hsu, P Supaphol, H Uludag Molecular Pharmaceutics 6 (6), 1798-1815, 2009 | 182 | 2009 |
| Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine A Alshamsan, A Haddadi, V Incani, J Samuel, A Lavasanifar, H Uludag Molecular pharmaceutics 6 (1), 121-133, 2009 | 181 | 2009 |
| Biodegradable amphiphilic poly (ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery XB Xiong, H Uludağ, A Lavasanifar Biomaterials 30 (2), 242-253, 2009 | 179 | 2009 |
| Characterization of absorbable collagen sponges as rhBMP-2 carriers W Friess, H Uludag, S Foskett, R Biron, C Sargeant International journal of pharmaceutics 187 (1), 91-99, 1999 | 177 | 1999 |
| Supramolecular assemblies in functional siRNA delivery: where do we stand? HM Aliabadi, B Landry, C Sun, T Tang, H Uludağ Biomaterials 33 (8), 2546-2569, 2012 | 158 | 2012 |
| Bisphosphonates as a foundation of drug delivery to bone H Uludag Current pharmaceutical design 8 (21), 1929-1944, 2002 | 146 | 2002 |
| A review of nanostructured surfaces and materials for dental implants: surface coating, patterning and functionalization for improved performance R Rasouli, A Barhoum, H Uludag Biomaterials science 6 (6), 1312-1338, 2018 | 144 | 2018 |
| Lipid and hydrophobic modification of cationic carriers on route to superior gene vectors V Incani, A Lavasanifar, H Uludağ Soft Matter 6 (10), 2124-2138, 2010 | 143 | 2010 |
| Molecular dynamics simulations of DNA/PEI complexes: effect of PEI branching and protonation state C Sun, T Tang, H Uludağ, JE Cuervo Biophysical journal 100 (11), 2754-2763, 2011 | 139 | 2011 |
| Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells XB Xiong, A Mahmud, H Uludağ, A Lavasanifar Pharmaceutical research 25, 2555-2566, 2008 | 137 | 2008 |
